At 4.9% CAGR, the Asia Pacific Embolization Coils Market is projected to be worth US$ 356.04 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Asia Pacific embolization coils market was valued at US$ 267.89 million in 2022 and is expected to reach US$ 356.04 million by 2028, registering a CAGR of 4.9% from 2022 to 2028. Growth in prevalence of cardiac aneurysm and upsurge in incidence of cancer cases are the critical factors attributed to the Asia Pacific embolization coils market expansion.

The market players are aggressively conducting research and development activities on embolization coils. Also, the market is dynamic and complex, characterized by recurrent product launches and plentiful clinical trials. The embolization coils market has various growth opportunities due to the rising prevalence of peripheral vascular disease, neurovascular diseases, cardiac conditions, and other chronic diseases that lead to vascular disorders. The current trend for endovascular treatments or embolization coils is interventional radiology. The treatment is a minimally invasive procedure under the guidance of X-rays. The benefits of interventional radiology have proven itself to be the best treatment option for the control of extensive blood flow. Interventional radiology is also helpful in the field of gynecology during cesarean section procedures where the patients experience extensive blood loss. The rise in the prevalence of liver and kidney cancer has contributed extensively to the need for treatment. The rise in the geriatric population, which is highly affected by endovascular diseases, brain stroke, heart stroke, and chronic diseases, is adding up to the market's growth. Therefore, interventional radiology is highly preferred for the geriatric population to treat diseases as it is a minimally invasive procedure. In addition, the other advantages, such as less hospital stay, fast recovery, and less dependence on others after the procedure, attract the patients more. This is expected to drive the Asia Pacific embolization coils market during the forecast period.

On the contrary, high rate of embolization coils hurdles the growth of Asia Pacific embolization coils market. 

Based on type, the Asia Pacific embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held 59.2% market share in 2022, amassing US$ 158.60 million. It is projected to garner US$ 214.92 million by 2028 to expand at 5.2% CAGR during 2022–2028.

Based on material, the Asia Pacific embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held 46.4% market share in 2022, amassing US$ 124.19 million. It is projected to garner US$ 169.42 million by 2028 to expand at 5.3% CAGR during 2022–2028.

Based on application, the Asia Pacific embolization coils market is categorized into neurology, cardiology, urology, oncology, peripheral vascular disease, and others. The neurology segment held 30.1% market share in 2022, amassing US$ 80.73 million. It is projected to garner US$ 111.53 million by 2028 to expand at 5.5% CAGR during 2022–2028.

Based on end user, the Asia Pacific embolization coils market is categorized into hospital, cardiac center, ambulatory center, and other. The hospital segment held 55.2% market share in 2022, amassing US$ 147.80 million. It is projected to garner US$ 201.88 million by 2028 to expand at 5.3% CAGR during 2022–2028.

Based on country, the Asia Pacific embolization coils market has been categorized into the China, Japan, India, Australia, South Korea, and Rest of Asia Pacific.  Our regional analysis states that China captured 27.8% market share in 2022. It was assessed at US$ 74.39 million in 2022 and is likely to hit US$ 101.83 million by 2028, exhibiting a CAGR of 5.4% during the forecast period.             

Key players dominating the Asia Pacific embolization coils market are Terumo Corporation; Medtronic; Boston Scientific Corporation; Stryker; KANEKA CORPORATION; MicroPort Scientific Corporation; Penumbra, Inc.; Cook Medical LLC; Johnson & Johnson Services, Inc.; and Shape Memory Medical INC. among others.

• In Jun 2022, Rapid Medical Marks First Procedures with Numen Coil from MicroPort Scientific.
• In May 2019, Shape Memory Medical gets FDA nod for Impede-FX embolization plug.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com